CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Mindfulness session(s)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D008881 Migraine Disorders NIH 0.58

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002076 Migraine HPO 0.58

There is one clinical trial.

Clinical Trials


1 Mindfulness During COVID-19 - Remote Mindfulness Sessions

The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.

NCT04319445 Migraine Disorders Stress Anxiety Behavioral: Mindfulness session(s)
MeSH:Migraine Disorders
HPO:Migraine

Primary Outcomes

Description: Total scale 1-5. Higher scores denotes better outcomes.

Measure: Helpfulness of the session

Time: Post-Intervention (upon completion of session up to 15 minutes)

Description: Total scale 1-5. Higher scores denotes better outcomes.

Measure: Platform effectiveness

Time: Post-Intervention (upon completion of session up to 15 minutes)

Secondary Outcomes

Description: Total scale 1-5. Higher scores denotes worse outcomes.

Measure: Change in Anxiety Level

Time: Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)

Description: Total scale 1-5. Higher scores denotes worse outcomes.

Measure: Change in Stress Level

Time: Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)

Description: Total scale 1-5. Higher scores denotes better outcomes.

Measure: Value of the session

Time: Post-Intervention (upon completion of session up to 15 minutes)

Description: Total scale 1-5. Higher scores denotes better outcomes.

Measure: Satisfaction with the session

Time: Post-Intervention (upon completion of session up to 15 minutes)

Measure: Percentage of participants that showed interest in a future session

Time: Post-Intervention (upon completion of session up to 15 minutes)

Measure: Percentage of participants that would recommend this session to a family member

Time: Post-Intervention (upon completion of session up to 15 minutes)

Description: Percentage of participants that would prefer to participate in daily, weekly or monthly similar sessions again if offered

Measure: Percentage of participants by session frequency preference

Time: Post-Intervention (upon completion of session up to 15 minutes)

Other Outcomes

Description: Total scale 1-5. Higher scores denotes worse outcomes.

Measure: Concern level about the COVID 19 pandemic

Time: Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)


Related HPO nodes (Using clinical trials)